alpha-fetoprotein protects female brains from oestrogens

1
Newsdesk “Lmx1a is a master regulator that can induce the generation of dopamine neurons when expressed outside of its normal expression domain,” Perlmann and Ericson explain. “It is functioning at the very top of the hierarchy and initiates the regulatory cascade that ultimately leads to the generation of fully mature dopamine neurons in a permissive territory.” Although these data do not exclude the participation of other genes, especially at the final differentiation steps, other experts on early development of the CNS recognise the relevance of the discovery. Marten Smidt (Rudolf Magnus Institute of Neuroscience, Utrecht, Netherlands) said “Lmx1a seems to be a genuine intrinsic factor that drives the initial induction process leading to a midbrain dopaminergic phenotype. It would be interesting now to see which dopaminergic subtype is induced”. Eduardo Puelles (Instituto de Neurociencias, Alicante, Spain) agrees that “these data might be crucial in designing therapeutic replacement strategies based on stem cells.” “Importantly—since obtaining authentic dopamine neurons is a prerequisite for cell replacement therapy in PD—we have also shown that when Lmx1a is expressed in mouse embryonic stem cells, bona fide dopamine neurons could be generated in cell culture”, said the authors. “It will be necessary now to focus intense efforts on transferring the method to human embryonic stem cells.” They also caution that “although some of the previous clinical trials using fetal human cells for transplantation have shown promising result, the picture is mixed, as other trials have failed. To move forward towards a more robust stem cell-based therapy, authentic dopamine neurons must first be generated and we are happy that our research on basic development mechanisms has provided an important step towards this goal.” Elena Becker-Barroso http://neurology.thelancet.com Vol 5 March 2006 207 Alpha-fetoprotein (AFP) has a role in sexual differentiation of the brain, but whether this protein protects female brains from the masculinising effects of oestrogens or whether it actively transports oestrogens into female brains was unclear. Now, researchers have created a mutant mouse lacking AFP in which to test these two opposing theories. “We have provided incontrovertible proof that AFP protects the female brain from becom- ing masculinised and defeminised by oestrogens”, says lead author Julie Bakker (University of Liège, Belgium). Bakker and colleagues assessed the sexual behaviour and sex differences in certain areas of the brain in female AFP knock-out mice (Nat Neurosci 2006; 9: 220–26). They found that female mice homozygous for the knock-out showed little or no typical female behaviour compared with heterozygous or wild-type littermates, and in fact showed signs of typical male behaviour. To see what effect lack of AFP had on the brains of female AFP / mice, the researchers examined the anteroventricular nucleus of the preoptic region (AVPv), an area of the brain that is critical for female repro- ductive function. Normal females have more neurons expressing tyrosine hydroxylase in this area of the brain than males. However, the numbers of neurons were similar in both AFP / female mice and wild-type males. To confirm the role of AFP in protecting female brains from oestro- gens, Bakker and colleagues blocked oestrogen production during prenatal development by treating pregnant mice with 1,4,6-androstatriene-3,17- dione, which blocks the conversion of testosterone to oestradiol. This treat- ment rescued female sexual behaviour and prevented the decrease in neurons expressing tyrosine hydroxylase in the AVPv. “The fact that the female phenotype of the AFP / mice could be rescued . . . shows that oestrogens are normally circulating in high concen- trations in fetal blood and that AFP protects the female brain from these oestrogens by sequestering them and preventing them from entering neurons”, concludes Bakker. “An interesting implication of this study is that there are sufficient oestrogens circulating in the blood of a female, just before or after birth, to cause nearly complete masculine differentiation of the brain”, comments Arthur Arnold (University of California, Los Angeles, CA, USA). However, he adds, “It is not known what, if anything, protects the human brain from maternal oestrogens, or indeed if such protection is required. The reigning idea is that in humans, androgens, not oestrogens, are the primary cause of brain masculinisation in males”. Geert de Vries (University of Massachusetts, MA, USA) adds: “I would be surprised that there would not be similar factors, perhaps inter- acting with androgens, that control differentiation in the human brain.” Rebecca Love Alpha-fetoprotein protects female brains from oestrogens Female brains are protected from maternal oestrogens Josh Sher/Science Photo Library Rights were not granted to include this image in electronic media. Please refer to the printed journal.

Upload: rebecca-love

Post on 19-Sep-2016

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Alpha-fetoprotein protects female brains from oestrogens

Newsdesk

“Lmx1a is a master regulator that caninduce the generation of dopamineneurons when expressed outside of itsnormal expression domain,” Perlmannand Ericson explain. “It is functioningat the very top of the hierarchy andinitiates the regulatory cascade thatultimately leads to the generation offully mature dopamine neurons in apermissive territory.”

Although these data do not excludethe participation of other genes,especially at the final differentiationsteps, other experts on earlydevelopment of the CNS recognise therelevance of the discovery. MartenSmidt (Rudolf Magnus Institute ofNeuroscience, Utrecht, Netherlands)

said “Lmx1a seems to be a genuineintrinsic factor that drives the initialinduction process leading to a midbraindopaminergic phenotype. It would beinteresting now to see whichdopaminergic subtype is induced”.Eduardo Puelles (Instituto deNeurociencias, Alicante, Spain) agreesthat “these data might be crucial indesigning therapeutic replacementstrategies based on stem cells.”

“Importantly—since obtainingauthentic dopamine neurons is aprerequisite for cell replacementtherapy in PD—we have also shownthat when Lmx1a is expressed inmouse embryonic stem cells, bona fidedopamine neurons could be generated

in cell culture”, said the authors. “It willbe necessary now to focus intenseefforts on transferring the method tohuman embryonic stem cells.” Theyalso caution that “although some ofthe previous clinical trials using fetalhuman cells for transplantation haveshown promising result, the picture ismixed, as other trials have failed. Tomove forward towards a more robuststem cell-based therapy, authenticdopamine neurons must first begenerated and we are happy that ourresearch on basic developmentmechanisms has provided animportant step towards this goal.”

Elena Becker-Barroso

http://neurology.thelancet.com Vol 5 March 2006 207

Alpha-fetoprotein (AFP) has a role insexual differentiation of the brain, butwhether this protein protects femalebrains from the masculinising effectsof oestrogens or whether it activelytransports oestrogens into femalebrains was unclear. Now, researchershave created a mutant mouse lackingAFP in which to test these twoopposing theories. “We have providedincontrovertible proof that AFPprotects the female brain from becom-ing masculinised and defeminised byoestrogens”, says lead author JulieBakker (University of Liège, Belgium).

Bakker and colleagues assessed thesexual behaviour and sex differencesin certain areas of the brain in femaleAFP knock-out mice (Nat Neurosci2006; 9: 220–26). They found thatfemale mice homozygous for theknock-out showed little or no typicalfemale behaviour compared withheterozygous or wild-type littermates,and in fact showed signs of typicalmale behaviour. To see what effectlack of AFP had on the brains of femaleAFP�/� mice, the researchers examinedthe anteroventricular nucleus of thepreoptic region (AVPv), an area of thebrain that is critical for female repro-ductive function. Normal females have

more neurons expressing tyrosinehydroxylase in this area of the brainthan males. However, the numbers ofneurons were similar in both AFP�/�

female mice and wild-type males.To confirm the role of AFP in

protecting female brains from oestro-gens, Bakker and colleagues blockedoestrogen production during prenataldevelopment by treating pregnantmice with 1,4,6-androstatriene-3,17-dione, which blocks the conversion oftestosterone to oestradiol. This treat-ment rescued female sexual behaviourand prevented the decrease in neuronsexpressing tyrosine hydroxylase in theAVPv. “The fact that the femalephenotype of the AFP�/� mice could berescued . . . shows that oestrogens arenormally circulating in high concen-trations in fetal blood and that AFPprotects the female brain from theseoestrogens by sequestering them andpreventing them from enteringneurons”, concludes Bakker.

“An interesting implication of thisstudy is that there are sufficientoestrogens circulating in the blood ofa female, just before or after birth, tocause nearly complete masculinedifferentiation of the brain”,comments Arthur Arnold (University

of California, Los Angeles, CA, USA).However, he adds, “It is not knownwhat, if anything, protects the humanbrain from maternal oestrogens, orindeed if such protection is required.The reigning idea is that in humans,androgens, not oestrogens, are theprimary cause of brain masculinisationin males”. Geert de Vries (University ofMassachusetts, MA, USA) adds: “Iwould be surprised that there wouldnot be similar factors, perhaps inter-acting with androgens, that controldifferentiation in the human brain.”

Rebecca Love

Alpha-fetoprotein protects female brains from oestrogens

Female brains are protected from maternal oestrogens

Josh

She

r/Sc

ienc

e Ph

oto

Libr

ary

Rights were not granted to include thisimage in electronic media. Please refer

to the printed journal.